Karyopharm Therapeutics Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Karyopharm Therapeutics Inc. for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.39 | 4,000 | 49,553 | 714,826 | 718.8 K to 714.8 K (-0.56 %) |
| Mar 23 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.39 | 4,000 | 49,553 | 714,826 | 718.8 K to 714.8 K (-0.56 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Grant | A | 0.00 | 22,013 | 0 | 107,691 | 85.7 K to 107.7 K (+25.69 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Grant | A | 0.00 | 22,013 | 0 | 51,755 | 29.7 K to 51.8 K (+74.01 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Grant | A | 0.00 | 22,013 | 0 | 45,401 | 23.4 K to 45.4 K (+94.12 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Grant | A | 0.00 | 22,013 | 0 | 104,439 | 82.4 K to 104.4 K (+26.71 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 14.56 | 43,177 | 628,657 | 43,177 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Grant | A | 0.00 | 15,849 | 0 | 23,995 | 8.1 K to 24 K (+194.56 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Grant | A | 0.00 | 57,200 | 0 | 718,826 | 661.6 K to 718.8 K (+8.65 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Grant | A | 0.00 | 57,200 | 0 | 920,152 | 863 K to 920.2 K (+6.63 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 920,152 | 863 K to 920.2 K (+6.63 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 718,826 | 661.6 K to 718.8 K (+8.65 %) |